Ticker Details
Rapport Therapeutics, Inc. Common Stock
IPO Date:	June 7, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.42B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.82 | 4.31%
Avg Daily Range (30 D):	$0.62 | 2.25%
Avg Daily Range (90 D):	$0.80 | 2.87%

Institutional Daily Volume
Avg Daily Volume:	.24M
Avg Daily Volume (30 D):	.27M
Avg Daily Volume (90 D):	.28M

Trade Size
Avg Trade Size (Sh.):	57
Avg Trade Size (Sh.) (30 D):	52
Avg Trade Size (Sh.) (90 D):	49

Institutional Trades
Total Institutional Trades:	278
Avg Institutional Trade:	$1.58M
Avg Institutional Trade (30 D):	$1.02M
Avg Institutional Trade (90 D):	$1.48M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.09M
Avg Closing Trade (30 D):	$1.14M
Avg Closing Trade (90 D):	$1.79M
Avg Closing Volume:	87.8K

News

Sep 10, 2025 @ 1:17 AM Rapport Announces Pricing of Public Offering of Co... Source: Globe Newswire

Jun 12, 2025 @ 8:22 PM Analysts Can't Get Enough of These Little-Known Bi... Source: Marketbeat.Com

Jun 2, 2025 @ 6:45 PM Rapport Therapeutics Hosts Investor and Analyst Da... Source: Rapport Therapeutics, Inc.

Mar 21, 2025 @ 11:00 AM Rapport Therapeutics to Present Data at the 2025 A... Source: N/A

Jan 9, 2025 @ 12:00 PM Rapport Therapeutics Announces New Phase 1 Data, F... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-2.27	$-.71	$-.75
Diluted EPS	$-2.27	$-.71	$-.75
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-97.7M	$-26.93M	$-26.73M
Operating Income / Loss	$-110.11M	$-29.99M	$-29.5M
Cost of Revenue
Net Cash Flow	$212.05M	$196.29M	$-2.54M
PE Ratio